These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy. Dalakas MC; Engel WK Arch Neurol; 1980 Oct; 37(10):637-40. PubMed ID: 6252877 [TBL] [Abstract][Full Text] [Related]
11. Idiopathic polyneuritis: serial studies of nerve and immune functions. McQuillen MP J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):607-15. PubMed ID: 4330698 [TBL] [Abstract][Full Text] [Related]
12. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients. Yan WX; Taylor J; Andrias-Kauba S; Pollard JD Ann Neurol; 2000 Jun; 47(6):765-75. PubMed ID: 10852542 [TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin G is remarkably beneficial in chronic immune dysschwannian/dysneuronal polyneuropathy, diabetes-2 neuropathy, and potentially in severe acute respiratory syndrome. Engel WK Acta Myol; 2003 Dec; 22(3):97-103. PubMed ID: 15088499 [TBL] [Abstract][Full Text] [Related]
14. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects. Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186 [TBL] [Abstract][Full Text] [Related]
15. [Motor nerve conduction velocity in uraemic polyneuropathy: correlation with metabolic factors (author's transl)]. Mamoli B; Kopsa H; Maly J; Pateisky K; Gerstenbrand F; Kotzaurek R Wien Klin Wochenschr; 1976 Dec; 88(23):770-4. PubMed ID: 1014710 [TBL] [Abstract][Full Text] [Related]
16. [Polyneuropathy associated with monoclonal gammopathy of undetermined significance]. Moth Henriksen M; Kolmos EB; Abildgaard N; Schrøder HD; Sindrup S Ugeskr Laeger; 2012 Oct; 174(43):2630-4. PubMed ID: 23095652 [TBL] [Abstract][Full Text] [Related]
17. Occurrence and isotype of antibodies against peripheral nerve myelin in serum from patients with peripheral neuropathy and healthy controls. Cruz M; Ernerudh J; Olsson T; Höjeberg B; Link H J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):820-5. PubMed ID: 3404188 [TBL] [Abstract][Full Text] [Related]
18. [Polyneuropathy index-revised in the evaluation of diabetic neuropathy]. Hasegawa O; Matsumoto S; Gondo G; Arita T No To Shinkei; 2001 Mar; 53(3):259-63. PubMed ID: 11296400 [TBL] [Abstract][Full Text] [Related]
19. From bench to bedside--experimental rationale for immune-specific therapies in the inflamed peripheral nerve. Meyer zu Hörste G; Hartung HP; Kieseier BC Nat Clin Pract Neurol; 2007 Apr; 3(4):198-211. PubMed ID: 17410107 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of chronic immune-mediated polyneuropathies. State of the art and perspectives]. Léger JM; Chassande B Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S19-23. PubMed ID: 10896984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]